Trends in the Incidence of Cancer in Ekiti, Southwestern Nigeria 2013 – 2017 First Results from Ekiti Cancer Registry
Article Sidebar
Main Article Content
Abstract
Abstract
Background
Data from the population-based cancer registries has been shown to be very useful for cancer research and development of national cancer control programmes. The data from other older population-based cancer registries outside Ekiti State was used in the past to develop cancer intervention which was not give a true picture of the reality. The Ekiti Cancer Registry was the first population-based cancer registry established in Ekiti State basically, to assess the incidence and monitor the trend of cancer in Ekiti State.
Methods: The data from Ekiti Cancer Registry was extracted in all laboratories, diagnostic centres, wards, clinics, death certificate and autopsy registers from health facilities and hospitals in the catchment area of the registry which are Ado and Ido-Osi Local Government where cancer cases are diagnosed and or managed. The data was abstracted and entered into CanReg 5 database. Analysis was conducted using the CanReg 5 software.
Results: We report the first cancer incidence results of the five years of registration (2013- 2017). A total of one thousand two hundred and six (1206) cases of cancer were registered; six hundred and forty-one (641) women with an ASR of 91.5 per 100,000 population and five hundred and sixty -five(565) men with an ASR 81.5 per 100,000 population. The top three common cancers recorded were Breast, Cervix and lymphomas in the women, and Prostate, Lymphomas and Colon cancer in men. Surprisingly, the ASR of Prostate Cancer (46.0 per 100,000) is higher than that of breast (ASR 39.5 per 100,000). These figures suggest a departure from most reports in this region which reported a higher ASR for breast cancer when compared to the prostate cancer.
Conclusion: There is an urgent need to further study the various epidemiological factors that might be responsible for the high ASR for Prostate Cancer. This is the very first cancer incidence report from Ekiti state, and this would provide the needed platform for a more specific cancer control programme in the geographical region.
KEYWORDS: Trends, Incidence, Cancer Registry, Ekiti, Nigeria.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
How to Cite
References
IARC’s Global Cancer Observatory [ Internet].2024 Feb 01. (cited 2024 Feb 20). Available from: http://gco.iarc.fr/today/end/data. sources. methods.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre L A, Jemal A. Global Cancer Statistics GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2018; 68:394-424.
Owen, O’ D. Access to health care in developing countries: breaking down demand side barriers. Cad. Saúde Pública. 2007: vol.23 no.12 Rio de Janeiro. . Accessed September 12,2023.
Sloan FA, Gelband H. Institute of Medicine (US) Committee on Cancer Control in Low- and Middle-Income Countries. Cancer Control Opportunities in Low- and Middle-Income Countries. Washington (DC): National Academies Press (US). 8, Cancer Centers in Low- and Middle-Income Countries. Available from: https://www.ncbi.nlm.nih.gov/books/NBK54037/2007. Accessed September 12, 2023.
National Research Council (US). The Continuing Epidemiological Transition in Sub-Saharan Africa: A Workshop Summary. Washington (DC): National Academies Press (US). The Epidemiological Transition in Africa: Are There Lessons from Asia? 2012. Available from: https://www.ncbi.nlm.nih.gov/books/NBK114529/.
Parkin DM, Ferlay J, Hamdi-Cheriff M, Sitas F, Thomas JO. editors. Cancer in Africa: Epidemiology and Prevention. IARC Press; Lyon. IARC Scientific Publications. 2003. No. 153
Parkin DM, Jemal A, Bray F, Korir AR, Kamate B, Singh E et al. Cancer in Sub-Saharan Africa Vol.III. Union for International Cancer Control Geneva, Switzerland. 2019.
Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG (eds): Cancer Registration: Principles and Methods, Lyon, France, International Agency for Research on Cancer, IARC Scientific Publication. 1991. No.95.
Piver MS: The Gilda Radner Familial Ovarian Cancer Registry 1981-2000. Euro J Gynaecol Oncol. 2000;325-333.
Wabinga HR, Nambooze S, Amulen PM, Okello C , Mbus L, Parkin DM. Trends in the incidence of cancer in Kampala, Uganda 1991–2010. Int. J. Cancer: 2013;(135): 432–439
Wang YC, Wei LJ, Liu JT, Li SX, Qing-sheng Wang QS. Comparison of Cancer Incidence between China and the USA. Cancer Biol Med.2012; 9(2): 128–132. doi: 10.3969/j.issn.2095-3941.2012.02.009
Zheng RS, Chen R, Han BF, Wang SM, Li L, Sun K et al. Cancer Incidence and Mortality in China, 2022. Journal of the national Cancer Center. 2024;(4):47-53.
African Cancer Registry Network. How to apply. http://afrcn.org/index.php/rearch/how -to-apply.
Nigerian System of Cancer Registries, National Institute for Cancer Research and Treatment (NSCR-NICRAT). Newsletter. 2024; 8(1): 13
Edington GM, Maclean CM. A cancer rate survey in Ibadan, Western Nigeria.br. J. Cancer.1965;471-481.
Adebamowo CA, Ajayi OO. Cancer in Nigeria. West Afr J Med. 2000;19(3): 170-91.
https://en.wikipedia.org/wiki/Ekiti State . Accessed August 16, 2023.
Federal Republic of Nigeria, National Policy on population for sustainable development. Federal Republic of Nigeria official gazette.2009; 96(2):837. Accessed August 16, 2023.
Finesse AM, Somdyala N, Chokunonga E, Parkin DM. Manual standard procedure for cancer registration in sub-saharan Africa. AFCRN 2015;111:20-43.
Percy C, Fritz A, Jack A, Shanmugarathan S, Sobin L, Parkin DM et al. International Classification of Diseases for Oncology (ICD-0), 3rd ed. Geneva: World Health Organization 2000.
Doll R, Smith PG. Comparison between registries; age-standardized rates in: Muir CS, Shanmugarathan (Eds). Cancer incidence in Five continents; 7, IARC Scientific Publication. 1982.pp 671-675.
Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood cancer, third edition. Cancer 2005; 103:1457-67.
The International Agency for Research on Cancer (IARC): The World Cancer Report 2020: Cancer Research for Cancer Prevention.
Torre LA, Siegel RL, Ward EM, Jemal A . Global cancer incidence and mortality rates and trends- an update. Cancer Epidemiol Biomarkers Prev.2015: OF1- OF12.
Okobia MN. Cancer acre in sub-Saharan Africa – Urgent need for population- based cancer registries. Ethiop. J. Health Dev.2003;17(2):89-98.
Bello-Morhason IO, Odedina F, Rebbeck TR, Danguo JM, Denny L, Adewole IF. Challenges and opportunities in cancer control in Africa: a perspective from the African Organization for Research and Training in Cancer. Lancet Oncol.2013; 14:e142-5.
Stefan DC. Cancer care in Africa: An overview of resources. J Glob Oncol 2015;1:30-36.
Boyle P, Ngoma T, Sullivan R, Brawley. Cancer in Africa: the way forward ecancer .2019:13 953.
Klassen AC, Platz EA. What can geography tell us about prostate cancer? Am J Prev. Med.2006; 30(2):57-S15).
https://ekitistate.gov.ng/about-ekiti/people-culture/. Accessed September 12, 2023.
Babatunde OA, Elegbede O, Ayodele LM, Sunday DA. Prevalence and outcome of Cancers in Ekiti state, southwest Nigeria. Journal of Clinical Oncology. 2013;31(15 suppl):suppl; 12553.DOI: 10.1200/jco.2013.31.15 suppl.e12553.
Parkin DM, Jemal A, Bray F, Korir AR, Kamate B, Singh E et.al. Cancer in Sub-Saharan Africa Vol.III. Union for International Cancer Control Geneva, Switzerland. 2019.
United Nations Economic Commission for Africa. The Demographic profile of Africa.https://www.uneca.org/sites/default/files/PublicationFiles/demographic profile revs april 25.pdf. Accessed September 24, 2023.
Jedy-Agba EE, Oga EA, Odutola M, Abdullahi YM, Popoola A, Achara P et al. Developing national cancer registration in developing countries-case study of the Nigerian national system of cancer registries.https://doi.org/10.3389/fpubh.2015.00186. Accessed July 2,2019.
Ekanem IA,Parkin DM. Five year cancer incidence in Calabar, Nigeria (2009-2013). Cancer Epidemiology. 2016;42:167-172.
Egue M,Gnangnon FH,Akele-Akpo M-T,Parkin DM. Cancer incidence in Cotonou (Benin) , 2014- 2016 ( First results from the cancer registry of Cotonou).https://doi.org/10.1016/j.canep.2019.01.006. Accessed May 15, 2020.
Aregbeshola BS, Khan MS. Out-of- pocket payments, catastrophic health expenditure and poverty among households in Nigeria . Int J Health Policy Manag. 2010;7(9):798-806.
Armstrong BK. The role of the cancer registry in cancer control. Cancer Causes & Control. 1992;3(6):569-579.
Schinasi L, Leon ME. Non-Hodgkin lymphoma and occupational exposure to agricultural pesticide chemical groups and active ingredients: a systematic review and meta-analysis. Int J Environ Res Public Health. 2018;11(4):4449-4527.
Omonisi A, Soremekun A, Olasode. Probable Risk Factors Responsible for the Increasing Trend of Non-Hodgkin’s Lymphoma in Ife-Ijesha Southwestern, Nigeria: A Call for an Epidemiological Study. European Journal of Research. 2020;5(7): 87-95
Ogunbiyi JO, Fabowale AO, Ladipo AA. Cancer Incidence and Top Ten cancers in Eleven Local Government Areas in Ibadan and its Environs,2004-2008: Ibadan Cancer Registry, Nigeria Technical Report.2010.
Omonisi A, Komolafe A, Adefehinti O, Olasode B, Lawal O, Durosinmi M et al. Cancer in Ife-Ijesha, Southwestern Nigeria: An Account of a 20- year Cancer Registration from Ife-Ijesha Cancer Registry International Journal of Internal Medicine .2020;9(1): 11-19.
Okongo F, Ogwang DM, Liu B, Parkin DM. Cancer incidence in Northern Uganda (2013-2016). Int.J. Cancer. https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.32053. Accessed May 17,2020.
Hämmerl L, Colombet M, Rochford R et al. The burden of Burkitt lymphoma in Africa. Infect Agents Cancer. 14, 17 https://doi.org/10.1186/s13027-019-0236-7.
Chinula L, Moses A, Gopal S. HIV-associated malignancies in sub-Saharan Africa: progress, challenges, opportunities. Curr Opin HIV AIDS. 2017 Jan; 12(1): 89–95.
Mabaso M., Makola L., Naidoo I, Mlangeni LL, Jooste S, Simbayi L. (2012). HIV prevalence in South Africa through gender and racial lenses: results from the 2012 population-based national household survey. Int J Equity Health .2012;18:167. https://doi.org/10.1186/s12939-019-1055-6.
Chan CK, Aimagambetova G, Ukybassova T, Kongrtay K, Azizan A. "Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination—Review of Current Perspectives", Journal of Oncology. https://doi.org/10.1155/2019/3257939. Accessed September 10, 2020.
Ghebre RG, Grover S, Xu M, Linus T. Chuang LT, Simonds H. Cervical cancer control in HIV-infected women: Past, present and future. Gynaecol Oncol Rep. 2017; 21: 101–108.
Jedy-Agba E, Curado MP, Ogunbiyi O, Oga E, Fabowale T, Osubor G et al. Cancer Incidence in Nigeria: A Report from Population-based Cancer Registries. Cancer Epidemiol.236 (5):e271-278.doi:10.1016/j.canep.2012.04.007. Accessed June 15,2019.
Sowunmi A, Alabi A, Fatiregun O, Olatunji T, Okoro US, Etti D et al. Trend of cancer incidence in an oncology center in Nigeria. West Afr J Radiol.2018; 25:52-6